遗传风险对2型糖尿病发病及血糖的影响:T2D-GENE生活方式干预试验
T2D-GENE试验纳入973名50-75岁、BMI≥25 kg/m2、空腹血糖5.6-6.9 mmol/L、HbA1c<48 mmol/mol的男性,按2型糖尿病遗传风险低或高分组,干预组接受3年小组式生活方式干预,对照组接受常规健康建议。高遗传风险组干预显著降低2型糖尿病风险(HR 0.30,95%CI 0.16-0.56,P<.001),低遗传风险组效果不显著(HR 0.69,95%CI 0.36-1.32,P=.262),两组干预效果无显著差异(P=.135)。
要点
- 高遗传风险组接受3年小组式生活方式干预后2型糖尿病风险显著降低(HR 0.30,95%CI 0.16-0.56,P<.001)。
- 低遗传风险组干预效果不显著(HR 0.69,95%CI 0.36-1.32,P=.262),两组间干预效果无显著差异(P=.135)。
- 干预显著改善低和高遗传风险组的血糖恶化并降低体重。
核心结论
- 高2型糖尿病遗传风险个体从低成本小组式健康饮食和体力活动干预中获益,所有2型糖尿病风险个体均应鼓励进行生活方式改变,无论遗传风险高低。
研究设计与样本
- T2D-GENE试验纳入973名来自代谢综合征男性(METSIM)队列的50-75岁男性,BMI≥25 kg/m2,空腹血糖5.6-6.9 mmol/L,HbA1c<48 mmol/mol,具有低或高2型糖尿病遗传风险评分。
- 干预组包括低遗传风险组(n=315)和高遗传风险组(n=313),接受3年小组式干预并可访问关注健康饮食和体力活动的网络平台。
- 对照组为相应的低遗传风险(n=196)和高遗传风险(n=149)人群基于人群的对照组,接受两次实验室访视(0年和3年)及作为METSIM队列方案一部分的一般健康建议。
- 主要结局为2型糖尿病发病,次要结局为血糖。
主要发现
- 高遗传风险组干预显著降低2型糖尿病风险(HR 0.30,95%CI 0.16-0.56,P<.001),低遗传风险组效果不显著(HR 0.69,95%CI 0.36-1.32,P=.262)。
- 高遗传风险组与低遗传风险组之间的干预效果无显著差异(P=.135)。
- 干预显著改善低遗传风险组和高遗传风险组的血糖恶化并降低体重。
临床怎么用
- 作者认为,所有2型糖尿病风险个体均应鼓励进行生活方式改变,无论遗传风险高低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Lifestyle intervention prevents or delays type 2 diabetes (T2D) in subjects at a high risk of T2D. However, it is not known whether genetic variants modify the effect on incident T2D during lifestyle intervention. OBJECTIVE: To investigate whether a low or high genetic risk has effects on incident T2D in a group-based lifestyle intervention study. METHODS: The T2D-GENE trial involved 973 men from the Metabolic Syndrome in Men (METSIM) cohort, aged 50-75 years, body mass index ≥25 kg/m2, fasting plasma glucose 5.6-6.9 mmol/L, hemoglobin A1c < 48 mmol/mol, and either a low or high genetic risk score for T2D. There were 2 intervention groups, a low (n = 315) and high genetic risk for T2D (n = 313). They were provided with a 3-year group-based intervention with access to a web portal focused on healthy diet and physical activity. There were also corresponding population-based control groups at low (n = 196) and high (n = 149) genetic risk for T2D who had two laboratory visits (0 and 3 years) and general health advice as a part of their METSIM cohort protocol. The primary outcome was incident T2D, and a secondary outcome was glycemia. RESULTS: The intervention significantly lowered the risk of T2D among the participants with a high genetic risk for T2D [hazards ratio (HR) 0.30, 95% confidence interval (CI) 0.16-0.56, P < .001) whereas in the low genetic risk group the effect was not significant (HR 0.69, 95% CI 0.36-1.32, P = .262). The intervention effect was not significantly different between the high and low genetic risk groups (P = .135). The intervention significantly ameliorated the worsening of glycemia and decreased weight both in the low and high genetic risk groups. CONCLUSION: Our results showed that individuals with a high genetic risk for T2D benefitted from a low-cost group-based intervention focusing on healthy diet and physical activity. Therefore, all individuals at risk of T2D should be encouraged to make lifestyle changes regardless of genetic risk.
引用
- Lankinen MA, Nuotio P, Kauppinen S, et al. Effects of Genetic Risk on Incident Type 2 Diabetes and Glycemia: The T2D-GENE Lifestyle Intervention Trial. J Clin Endocrinol Metab. 2024. PMID: 38888187. doi:10.1210/clinem/dgae422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。